Physician profile
Erik Stapleton
NPI 1033566369
$22,196.57
in general payments reported to CMS, 2019-2025
11 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,984 · 2022: $10K · 2023: $1,905 · 2024: $1,823 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,630 · Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,630.20 |
| Food and Beverage | $1,230.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,016.90 | 2021-2022 | |
| Arthrex, INC. | $3,993.05 | 2022-2024 | |
| Stryker Corporation | $3,372.68 | 2022-2025 | Insignia, Variax, Triathlon |
| Medical Device Business Services, INC. | $3,004.68 | 2021-2022 | |
| Mid-Atlantic Surgical Systems, LLC | $1,560.91 | 2022-2024 | |
| Vericel Corporation | $108.86 | 2022 | |
| Avanos Medical | $70.36 | 2023 | On-Q* Pump and Accessories |
| Bioventus LLC | $20.38 | 2024 | Exogen Ultrasound Bone Healing System |
| Endo Pharmaceuticals INC. | $19.45 | 2023 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $17.38 | 2022 | |
| Merck Sharp & Dohme LLC | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.